0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

From JAMA's Daily News Site |  May 15, 2013
Selections From News@JAMA and JAMA Forum
JAMA. 2013;309(19):1983. doi:10.1001/jama.2013.5120.
Medical News and Perspectives |  May 01, 2013
Study Ignites Debate on New Anticoagulant
Mike Mitka, MSJ
JAMA. 2013;309(17):1763-1764. doi:10.1001/jama.2013.3857.
JAMA Patient Page |  April 17, 2013 FREE
Aspirin Therapy
Janet M. Torpy, MD; Edward H. Livingston, MD
JAMA. 2013;309(15):1645. doi:10.1001/jama.2013.3866.
INCLUDES: , Supplemental Content
Original Contribution |  April 03, 2013
Mortality Rates for Medicare Beneficiaries Admitted to Critical Access and Non–Critical Access Hospitals, 2002-2010
Karen E. Joynt, MD, MPH; E. John Orav, PhD; Ashish K. Jha, MD, MPH
JAMA. 2013;309(13):1379-1387. doi:10.1001/jama.2013.2366.
INCLUDES: , Supplemental Content
Clinical Review |  March 27, 2013
Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma:  A Systematic Review
Sandra Y. Lin, MD; Nkiruka Erekosima, MD, MPH; Julia M. Kim, MD, MPH; et al.
JAMA. 2013;309(12):1278-1288. doi:10.1001/jama.2013.2049.
INCLUDES: CME , Supplemental Content
Editorial |  March 27, 2013
Is Sublingual Immunotherapy Ready for Use in the United States?
Harold S. Nelson, MD
JAMA. 2013;309(12):1297-1298. doi:10.1001/jama.2013.2739.
Editorial |  March 27, 2013
Macrolides and Bronchiectasis:  Clinical Benefit With a Resistance Price
J. Stuart Elborn, MD; Michael M. Tunney, PhD
JAMA. 2013;309(12):1295-1296. doi:10.1001/jama.2013.2780.
Original Contribution |  March 27, 2013
Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis:  The BAT Randomized Controlled Trial
Josje Altenburg, MD; Casper S. de Graaff, MD; Ymkje Stienstra, MD, PhD, MSc; et al.
JAMA. 2013;309(12):1251-1259. doi:10.1001/jama.2013.1937.
INCLUDES: , Supplemental Content
Original Contribution |  March 27, 2013
Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis:  The BLESS Randomized Controlled Trial
David J. Serisier, MBBS, DM, FRACP; Megan L. Martin, BN; Michael A. McGuckin, BSc, PhD; et al.
JAMA. 2013;309(12):1260-1267. doi:10.1001/jama.2013.2290.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  March 20, 2013
FDA: No Codeine After Tonsillectomy for Children
Bridget M. Kuehn, MSJ
JAMA. 2013;309(11):1100. doi:10.1001/jama.2013.2403.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 1, 2013
Use of Glucocorticoids and Risk of Venous Thromboembolism:  A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir, BSc; Erzsébet Horváth-Puhó, MSc, PhD; Olaf M. Dekkers, MD, PhD, MSc, MA; et al.
JAMA Internal Medicine
In This Issue of JAMA Internal Medicine  |  May 13, 2013
In This Issue of JAMA Internal Medicine
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?
Kristian B. Filion, PhD; Jonathan Assayag, MSc; Laurent Azoulay, PhD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply
Daniel M. Witt, PharmD; Thomas Delate, PhD; Mark A. Crowther, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems